Stock Price
2.90
Daily Change
0.08 2.84%
Monthly
1.75%
Yearly
-19.22%
Q1 Forecast
2.82

Bioline Rx reported $831K in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
Arca Biopharma USD 5.16M 346K Mar/2025
Bio Path USD 1.26M 456K Mar/2025
Bioline Rx USD 831K 622K Sep/2025
Capricor Therapeutics USD 5.88M 1.6M Mar/2025